Combined innovation delivers enterprise-grade security and unprecedented battery life for connected devices; Companies invite attendees to meet them at CES 2026Combined innovation delivers enterprise-grade security and unprecedented battery life for connected devices; Companies invite attendees to meet them at CES 2026

Afero and Atmosic to Usher in a New Era of Ultra-Secure and Ultra-Long-Battery-Life IoT Products

Combined innovation delivers enterprise-grade security and unprecedented battery life for connected devices; Companies invite attendees to meet them at CES 2026

LOS ALTOS, Calif. & SAN JOSE, Calif.–(BUSINESS WIRE)–Afero, the Made-in-the-USA enterprise-grade secure IoT Platform, and Atmosic Technologies, the leader in ultra-low-power Bluetooth® Low Energy (BLE) connectivity and compute solutions, today announced a strategic collaboration to create a new category of ultra-secure, ultra-long-battery-life Internet-of-Things (IoT) products. This collaboration delivers industry-leading smart products that combine a robust secure-by-design architecture, ease of use, and unprecedented battery life, paving the way for new applications across commercial, industrial, and consumer sectors.

Key highlights of the collaboration:

  • Ultra-secure IoT: The new products are built on Afero’s enterprise-grade IoT platform, ensuring end-to-end data integrity and protection from the device to the cloud.
  • Ultra-long battery life: The integration of Atmosic’s ultra-low-power BLE connectivity and compute silicon dramatically minimizes power consumption, enabling connected devices with unparalleled longevity on a single battery.
  • Anywhere connectivity: Made possible by the Afero Secure Bridge software, this capability allows customers to seamlessly control devices from anywhere in the world while extending battery life, which was previously difficult to achieve.

“The market has been waiting for IoT solutions that don’t force a compromise between security, remote access, and power efficiency,” said Joe Britt, CEO and Co-Founder of Afero. “By combining Afero’s proven, end-to-end security and the power-saving innovation of the Afero Secure Bridge software with Atmosic’s industry-leading, ultra-low-power BLE chips, we are setting a new standard for what is possible in connected products. We are thrilled to showcase this breakthrough at CES.”

“Longest battery life and robust security are essential to scaling IoT deployments and remain non-negotiable requirements for enterprise adoption,” said Ali Foughi, CEO of Atmosic. “Our collaboration with Afero accomplishes both priorities. We are delivering value to our customers and advancing the IoT industry.”

First products built on this joint solution are scheduled to arrive in 2026, beginning with mass-market smart home products from the largest home improvement retailer. More smart home products, as well as innovative solutions for asset tracking, industrial, and other applications are planned.

Meet Afero and Atmosic at CES 2026

Attendees of CES 2026 are invited to meet with both companies to see demonstrations of these next-generation IoT solutions at Wynn Tower Suites, Las Vegas. Please contact press@afero.io or PR@atmosic.com for meeting requests.

About Afero

Afero enables connected devices to be smart and secure. Afero’s IoT Platform as a Service prioritizes security, data privacy, simplicity, and ease of use throughout the end user experience. These key elements are integral to the solution and not bolted on after the fact, enabling manufacturers and brands to secure their supply chain. Afero technology powers millions of devices across 200 product categories from 50+ manufacturers. Afero is a privately held company based in Los Altos, Calif., and backed by distinguished investors such as Crosspoint Capital. For more information, visit https://afero.io/

About Atmosic Technologies

Atmosic™ is an innovative technology company designing ultra-low power wireless connectivity and compute solutions. These solutions are enabling the longest battery life in various applications in Consumer Devices, Home Automation, Healthcare, Industrial, and Enterprise markets.

Contacts

Afero Media Contact
press@afero.io

Atmosic Technologies Media Contact
PR@atmosic.com

Market Opportunity
ERA Logo
ERA Price(ERA)
$0.2181
$0.2181$0.2181
-0.27%
USD
ERA (ERA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23